Hemoclear joins forces with VDL HemoClear joins forces with VDL in manufacturing the HemoClear autologous blood filter. The Dutch innovation HemoClear is t
In the strategic ambition to optimize production, increase flexibility, and decrease lead times and costs, HemoClear will centralize all production
As a proud sponsor, HemoClear attended the Bloodless Medicine and Surgery Society Annual Meeting. At the event Dr Rosita Bihariesingh presented a case of s
After celebrating Bloodless Medicine and Surgery Day on May 16, HemoClear is attending the Annual Bloodless Medicine and Surgery Week Conference. On Thursd
78% mortality reduction in ICU-admitted COVID-19 patients in Suriname after treatment with convalescent plasma (CP) obtained by the HemoClear blood filter.
HemoClear B.V. received CE Mark approval for its first-in-class, technology, the HemoClearTM autologous blood filter
As a proud sponsor, HemoClear is attending the 28th Nigerian Society of Anaesthetists Annual Scientific Conference. Dr Rosita Bihariesingh has been at the
HemoClear attends the Bloodless Medicine & Surgery Society 2020 Annual Scientific Conference. Our Chief Medical Officer, Dr Arno Nierich, will present
COVID-19 plasma donatie geeft vroeg in het genezingsproces een hogere opbrengst van antistoffen dan later in dat proces. https://www.rtvoost.nl/nieuws/1271
Zwolle, 14 september 2020. Het Academisch Medisch Centrum (AZP) in Paramaribo, Suriname, heeft met succes onderzoek gedaan naar een efficiënte methode om